T1	Participants 1378 1513	Overall, these findings indicate that there are no apparent advantages in toxicity and efficacy by giving CDA weekly rather than daily.
T2	Participants 846 909	There was no significant difference in average leukocyte count.
T3	Participants 334 418	This trial compared toxicity and efficacy of weekly versus daily CDA administration.
